Mooreland Partners, a provider of M&A and private capital advisory services to the global technology industry, has acted as the exclusive financial advisor to OptoFidelity, an automated test technology provider for smart devices, on its sale to Changyuan Group. OptoFidelity Oy, based in Tampere, Finland, is a provider of innovative
NOW Money has closed its bridge funding round with a total of USD1.46 million in commitments. In addition to a recent US Venture Capital investment, this funding round includes USD700,000 from Dubai-based Venture Capital firm, Myrisoph Capital. Other contributions have come from private investors and MENA-based women’s investor network WAIN.
OrbiMed, an investment firm focused on the healthcare sector, has closed its third Asia-focused private equity fund, OrbiMed Asia Partners III, LP, with approximately USD551 million in capital commitments. Consistent with its predecessor funds, Asia Partners III will invest broadly across the Asian healthcare industry, with a focus on growth
StageOne Ventures, an early stage venture capital firm focusing on Israel-related technology startups, has closed ts third venture capital fund, with USD110 million in committed capital. Led by Yuval Cohen, Yoav Samet, and Tal Slobodkin, with presence both in Tel Aviv and in Palo Alto, StageOne Ventures helps entrepreneurs traverse
Albion Capital is seeking to raise up to GBP38 million through top up offers for its six venture capital trusts (VCTs). The fundraising targets GBP8 million for Kings Arms Yard VCT and GBP6 million across each of Albion’s other VCTs. Investments spread across all six portfolios will receive a monthly
Withinlink CEO Bessie Lee (pictured), has announced the launch of the firm’s second venture capital fund this year – a new USD30 million fund that is aiming to bring startups to China. “As our world globalises and China gentrifies, there has never been a better time to bridge the gap
Private equity firm Activa Capital’s portfolio company Mecadaq, a provider of high precision manufacturing for the aerospace industry, has acquired Armoa, a specialist in high precision machining. The acquisition takes place 18 months after the creation by Activa Capital of a consolidation platform in aerospace subcontracting. This is the second
AMAL Therapeutics (AMAL), a Swiss biotech developing peptide-based therapeutic cancer vaccines, has completed the first tranche of its Series B financing round, raising EUR8 million (CHF8.8 million). The Company will use the funds to progress its lead vaccine (ATP128) towards clinical studies and proof-of-concept in colorectal cancer. It will also
McCarthy Denning has advised Rockpool Acquisitions (Rockpool) in relation to its admission to the Standard Listing segment of the main market of the London Stock Exchange and a related fundraising. Gross proceeds of GBP1,085,000 were raised through the fundraising. Rockpool is a Special Purpose Acquisition Company (“SPAC”) founded in Northern
Shore Capital Partners platform company Argentum Medical has acquired the TheraBond family of products from Alliqua BioMedical (Alliqua). These products, branded TheraBond with unique SilverTrak technology, include contact dressings, island dressings and wraps for burn care, surgical site care, and wound care. “Alliqua has done an excellent job establishing
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
